SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-020851
Filing Date
2014-11-14
Accepted
2014-11-14 16:06:47
Documents
14
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vbiv20140930_10q.htm 10-Q 771296
2 EXHIBIT 10.12 ex10-12.htm EX-10 40144
3 EXHIBIT 31.1 ex31-1.htm EX-31 14472
4 EXHIBIT 31.2 ex31-2.htm EX-31 15517
5 EXHIBIT 32.1 ex32-1.htm EX-32 6187
6 EXHIBIT 32.2 ex32-2.htm EX-32 6233
7 EXHIBIT 99.1 ex99-1.htm EX-99 20690
14 header1.jpg GRAPHIC 24863
  Complete submission text file 0001437749-14-020851.txt   4736515

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS vbiv-20140930.xml EX-101.INS 612576
9 EXHIBIT 101.SCH vbiv-20140930.xsd EX-101.SCH 41141
10 EXHIBIT 101.CAL vbiv-20140930_cal.xml EX-101.CAL 29867
11 EXHIBIT 101.DEF vbiv-20140930_def.xml EX-101.DEF 221126
12 EXHIBIT 101.LAB vbiv-20140930_lab.xml EX-101.LAB 296339
13 EXHIBIT 101.PRE vbiv-20140930_pre.xml EX-101.PRE 215605
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Filer) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-18188 | Film No.: 141224079
SIC: 2836 Biological Products, (No Diagnostic Substances)